Showing 621 - 640 results of 3,171 for search '(( significant decrease decrease ) OR ( significant ((all decrease) OR (a decrease)) ))~', query time: 0.36s Refine Results
  1. 621

    MRI-based cochlear hydrops grading and PLE in MD. by Neda Azarpey (20308334)

    Published 2024
    “…Adjusting the threshold to EH grade 2 results in a sensitivity increase to 92.1% (CI: 85.9–95.7) and a specificity decrease to 70.6% (CI: 64.5–76.1), with a DOR of 28.056 (CI: 14.917–52.770). …”
  2. 622

    Cochlear hydrops classification in MRI systems. by Neda Azarpey (20308334)

    Published 2024
    “…Adjusting the threshold to EH grade 2 results in a sensitivity increase to 92.1% (CI: 85.9–95.7) and a specificity decrease to 70.6% (CI: 64.5–76.1), with a DOR of 28.056 (CI: 14.917–52.770). …”
  3. 623

    Atg14 plays a cell-intrinsic role in orchestrating eTreg survival but not terminal differentiation. by Erienne G. Norton (9612079)

    Published 2025
    “…Pearson’s correlation (<b>A</b>), Benjamini–Hochberg test (<b>B</b>), two-tailed Student <i>t</i> test (<b>C</b>–<b>E, G</b>–<b>J</b>), or Fisher’s exact test (<b>F</b>); NS, not significant. …”
  4. 624

    Histological scoring system of burned dermis. by Omid Mehrpour (9385929)

    Published 2024
    “…The body weight in Opium 5% significantly decreased compared to all other groups after ten days. …”
  5. 625

    Histological scoring system of burned epidermis. by Omid Mehrpour (9385929)

    Published 2024
    “…The body weight in Opium 5% significantly decreased compared to all other groups after ten days. …”
  6. 626

    Survival curve of ART Treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

    Published 2025
    “…Descriptives statistics were used to summarize all variables. Meanwhile, to analyze the temporal-trend plot of incidence over the study years, the data were modeled using a Generalized Linear Model (GLM) with a Poisson distribution. …”
  7. 627
  8. 628

    S1 File - by Valérie Chetboul (579758)

    Published 2025
    “…The inbreeding coefficient, which was assessed from the pedigree analysis of all screened dogs except one, was not significantly different between dogs with either AS (0.59%; P = 0.86) or PS (0.39%; P = 0.72) and those without any arterial stenosis (0.39%).…”
  9. 629

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  10. 630

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  11. 631

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  12. 632

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  13. 633

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  14. 634

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  15. 635

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  16. 636

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  17. 637
  18. 638

    Definitions of variables. by Qi Zhang (28502)

    Published 2024
    “…<div><p>Promoting the seamless integration of the digital economy with the real economy, mitigating the adverse impacts of widespread corporate tax avoidance, and optimizing tax governance are critical imperatives in the era of digital economy. This study examines all A-share listed companies from 2007 to 2022 as research samples. …”
  19. 639

    PSM and Heckman regression results. by Qi Zhang (28502)

    Published 2024
    “…<div><p>Promoting the seamless integration of the digital economy with the real economy, mitigating the adverse impacts of widespread corporate tax avoidance, and optimizing tax governance are critical imperatives in the era of digital economy. This study examines all A-share listed companies from 2007 to 2022 as research samples. …”
  20. 640

    Other robustness test regression results. by Qi Zhang (28502)

    Published 2024
    “…<div><p>Promoting the seamless integration of the digital economy with the real economy, mitigating the adverse impacts of widespread corporate tax avoidance, and optimizing tax governance are critical imperatives in the era of digital economy. This study examines all A-share listed companies from 2007 to 2022 as research samples. …”